MarketPeel
Insider Trading Intelligence
Pricing
…
CV

Carol A. Vallone

DFTX
DIRECTOR · DEFINIUM THERAPEUTICS, INC. · CIK 0001422058
FILING MIX · LIFETIME100%/0%
BUYS
2
SELLS
0
TOTAL VALUE
$0
COMPANIES
1
ACTIVE SINCE
Jun 2026
HOLDINGS NOW
21,210
AVG SELL PX
—
TRADE KIND
SHOWING 2 / 2
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
No backtest data available for Carol A. Vallone. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.
Holdings over time
DFTX · 21,210 shares · as of Jun 11, 2026
05,30310,60515,90821,210SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2026
FLOW · 2 buys / 0 sellsCOVERAGE · 1 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILED
DFTX
DEFINIUM THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
4,666——21,210Jun 11, 2026Jun 15, 2026 ↗
DFTX
DEFINIUM THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
19,188——19,188Jun 11, 2026Jun 15, 2026 ↗
Other insiders · DFTX
Loading peer insiders…
About this filer
CIK 0001422058
ROLE
Director
PRIMARY
DFTX
COMPANIES
1
ACTIVE SINCE
Jun 2026
MARKETPEEL · /INSIDER/0001422058DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback